Vision Rehabilitation: A Path to Emerge from Darkness
We extend warm congratulations to Professors Hanah Margalit and Guy Stroumsa for winning the prestigious 2020 Rothschild Prize.
The Rothschild Prize is awarded once every two years (in Sciences) and once every four years (in Humanities and Social Sciences), and is considered one of the top three prestigious prizes that is awarded to academic researchers in Israel.
Dr. Amal is an Assistant Professor in the Institute for Drug Research, School of Pharmacy, Faculty of Medicine at the Hebrew University of Jerusalem. His lab studies neurological disorders such as the autism spectrum and Alzheimer's disease using advanced omics technologies combined with bioinformatics, pharmacological, biochemical, biological, and behavioral methods. Specifically, Dr. Amal's lab is interested in the role of nitric oxide and S-nitrosylation in these disorders.
Prof. Marta Weinstock-Rosin of the Hebrew University's School of Pharmacy - Institute for Drug Research developed Exelon, a breakthrough drug that treats the symptoms of mild to moderate Alzheimer’s disease. Exelon slows the progression of the disease in many patients and often improves their cognitive function as well. The drug is manufactured by Novartis in Switzerland.
Prof. Simon Benita of the School of Pharmacy at the Faculty of Medicine developed Cationorm, an eye-drop nanoemulsion for the treatment of dry eyes. This emulsion consists of positively-charged oil nanodroplets and functions similarly to the physiological tear-making mechanism which lubricates the eyes and keeps them moist. Cationorm is manufactured by Novagali Pharma (France), which is owned by Santen Pharmaceuticals (Japan).
The MAZE Water Purification System was developedby Medicinal Chemistry Prof. Avi Domb of the Hebrew University's School of Pharmacy. The MAZA system comprises an innovative filter installed in portable water purification systems. It cleanses the water of organic and inorganic toxic residues as well as bacteria and viruses. Both the filter and water purification system are currently manufactured by Strauss-Haier in China.
The European Friends of The Hebrew University are proud to announce the launch of the fall-winter webinar series, which will take place October 2019 through January 2020. The monthly webinars will feature leading academics speaking about their research and work at the University.
The increasing ability to harness cannabidiol, a derivative of cannabis, to treat medical problems is due to the body’s endocannabinoid system (ECS).
This system, discovered by scientists at the Hebrew University of Jerusalem, is a set of natural pathways in our brain and body which carry messages to various regions to manage and regulate pain, appetite, mood regulation, and memory.
Israel Cancer Research Fund approved grants to the Hebrew University, and other Israeli institutions, for studies in blood, brain, breast, colorectal and many other types of cancers.
Prof. Yinon Ben-Neriah, of Hebrew University’s Faculty of Medicine, and 2019 EMET laureate, will be able to pursue further groundbreaking work on chronic myelogenous leukemia, due to this grant.
OrCam Technologies Ltd. is a start-up founded by Hebrew University Professor Amnon Shashua and Mr. Ziv Aviran, who also co-founded Mobileye in 1999. Mobileye is based on Hebrew University Technology.
Karthikeyan Pandi is a PhD student in the Faculty of Dental Medicine.
The Hebrew University of JerusalemDivision for Advancement and External RelationsMount Scopus 91905Jerusalem, IsraelTelephone: +972-2-588-2804
> Hebrew University Main Website
> Hebrew University Alumni Association
> Rothberg International School
> Hebrew University International Office
> Israeli Friends of the Hebrew University